Pseudomonas aeruginosa

20,394views

Pseudomonas aeruginosa

5600

5600

Anatomy of the larynx and trachea
Bones and joints of the thoracic wall
Vessels and nerves of the thoracic wall
Anatomy of the lungs and tracheobronchial tree
Muscles of the thoracic wall
Anatomy of the pleura
Development of the respiratory system
Nasal cavity and larynx histology
Bronchioles and alveoli histology
Trachea and bronchi histology
Respiratory system anatomy and physiology
Ventilation-perfusion ratios and V/Q mismatch
Ventilation
Alveolar surface tension and surfactant
Upper respiratory tract infection
Sinusitis
Retropharyngeal and peritonsillar abscesses
Laryngitis
Bacterial epiglottitis
Anatomy of the pharynx and esophagus
Anatomy of the superior mediastinum
Anatomy of the inferior mediastinum
Regulation of pulmonary blood flow
Zones of pulmonary blood flow
Airflow, pressure, and resistance
Breathing cycle and regulation
Lung volumes and capacities
Pulmonary edema
Anatomic and physiologic dead space
Pulmonary shunts
Diffusion-limited and perfusion-limited gas exchange
Alveolar gas equation
Gas exchange in the lungs, blood and tissues
Anatomy clinical correlates: Thoracic wall
Anatomy clinical correlates: Pleura and lungs
Otitis media
Eustachian tube dysfunction
Corynebacterium diphtheriae (Diphtheria)
Haemophilus influenzae
Bacterial tracheitis
Pediatric upper airway conditions: Clinical
Rhinovirus
Adenovirus
Moraxella catarrhalis
Streptococcus pyogenes (Group A Strep)
Streptococcus pneumoniae
Human parainfluenza viruses
Epstein-Barr virus (Infectious mononucleosis)
Influenza virus
Pediatric ear, nose, and throat conditions: Clinical
Alpha 1-antitrypsin deficiency
Compliance of lungs and chest wall
Combined pressure-volume curves for the lung and chest wall
Breathing cycle
Allergic rhinitis
Nasopharyngeal carcinoma
Oral cancer
Nasal polyps
Warthin tumor
Sjogren syndrome
Nasal, oral and pharyngeal diseases: Pathology review
Choanal atresia
Sialadenitis
Aphthous ulcers
Sleep apnea
Thoracic outlet syndrome
Neonatal respiratory distress syndrome
Cystic fibrosis
Cystic fibrosis: Clinical
Cystic fibrosis: Pathology review
Restrictive lung diseases
Restrictive lung diseases: Pathology review
Idiopathic pulmonary fibrosis
Sarcoidosis
Hypersensitivity pneumonitis
Obstructive lung diseases: Pathology review
Chronic bronchitis
Emphysema
Asthma
Asthma: Clinical
Bronchiectasis
Type I hypersensitivity
Pharmacodynamics: Desensitization and tolerance
Pneumonia: Pathology review
Pneumonia
Pneumonia: Clinical
Mycoplasma pneumoniae
Pulmonary changes at high altitude and altitude sickness
Oxygen-hemoglobin dissociation curve
Bronchodilators: Leukotriene antagonists and methylxanthines
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Mycobacterium tuberculosis (Tuberculosis)
Antituberculosis medications
Tuberculosis: Pathology review
Respiratory syncytial virus
Lung cancer
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Pancoast tumor
Horner syndrome
Superior vena cava syndrome
Chronic obstructive pulmonary disease (COPD): Clinical
Chlamydia pneumoniae
Coxiella burnetii (Q fever)
Klebsiella pneumoniae
Streptococcus pneumoniae
Pseudomonas aeruginosa
Chronic granulomatous disease
Bordetella pertussis (Whooping cough)
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Pleural effusion: Clinical
Pleural effusion
Pneumothorax: Clinical
Pneumothorax
Acute respiratory distress syndrome
Acute respiratory distress syndrome: Clinical
Pulmonary hypertension
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Pulmonary embolism
Pulmonary hypoplasia
Congenital diaphragmatic hernia
Mesothelioma
Respiratory distress syndrome: Pathology review
Pulmonary changes during exercise
Pulmonary chemoreceptors and mechanoreceptors
Pulmonary corticosteroids and mast cell inhibitors
Syncope: Clinical
Anatomy of the heart
Anatomy of the coronary circulation
ECG rate and rhythm
ECG normal sinus rhythm
ECG QRS transition
Cardiac conduction system
Normal heart sounds
Vasculitis: Clinical
Aortic aneurysms and dissections: Clinical
Vascular tumors
Aneurysms
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Raynaud phenomenon
Deep vein thrombosis
Deep vein thrombosis and pulmonary embolism: Pathology review
Thrombophlebitis
Lymphedema
Angiosarcomas
Cardiac and vascular tumors: Pathology review
Sturge-Weber syndrome
Vasculitis: Pathology review
Kawasaki disease
Kawasaki disease: Clinical
Mitral valve disease
Tricuspid valve disease
Aortic valve disease
Pulmonary valve disease
Introduction to the cardiovascular system
Development of the cardiovascular system
Fetal circulation
Cardiac muscle histology
Arteriole, venule and capillary histology
Artery and vein histology
Cardiovascular system anatomy and physiology
Coronary circulation
Lymphatic system anatomy and physiology
Blood pressure, blood flow, and resistance
Laminar flow and Reynolds number
Compliance of blood vessels
Pressures in the cardiovascular system
Resistance to blood flow
Control of blood flow circulation
Microcirculation and Starling forces
Measuring cardiac output (Fick principle)
Frank-Starling relationship
Stroke volume, ejection fraction, and cardiac output
Cardiac afterload
Cardiac preload
Law of Laplace
Cardiac contractility
Cardiac and vascular function curves
Altering cardiac and vascular function curves
Cardiac cycle
Pressure-volume loops
Cardiac work
Changes in pressure-volume loops
Abnormal heart sounds
Action potentials in myocytes
Excitability and refractory periods
Action potentials in pacemaker cells
Cardiac excitation-contraction coupling
Cardiac conduction velocity
ECG basics
ECG intervals
ECG axis
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Transposition of the great vessels
Tetralogy of Fallot
Persistent truncus arteriosus
Total anomalous pulmonary venous return
Hypoplastic left heart syndrome
Patent ductus arteriosus
Coarctation of the aorta
Ventricular septal defect
Atrial septal defect
Human herpesvirus 8 (Kaposi sarcoma)
Lymphangioma
Chronic venous insufficiency
Vasculitis
Behcet's disease
Aortic dissection
Marfan syndrome
Myocarditis
Endocarditis
Rheumatic heart disease
Pericarditis and pericardial effusion
Cardiac tamponade
Arterial disease
Angina pectoris
Unstable angina
Myocardial infarction
Prinzmetal angina
Hypertension
Hypertensive emergency
Renal artery stenosis
Orthostatic hypotension
Hypotension
Atrial flutter
Atrial fibrillation
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Dyslipidemias: Pathology review
Hypertension: Pathology review
Endocarditis: Pathology review
Pericardial disease: Pathology review
Shock
Shock: Clinical
Shock: Pathology review
Premature atrial contraction
Wolff-Parkinson-White syndrome
Atrioventricular nodal reentrant tachycardia (AVNRT)
Ventricular tachycardia
Premature ventricular contraction
Ventricular fibrillation
Brugada syndrome
Long QT syndrome and Torsade de pointes
Atrioventricular block
Bundle branch block
Heart failure
Cor pulmonale
Heart failure: Clinical
Heart failure: Pathology review
Positive inotropic medications
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Class III antiarrhythmics: Potassium channel blockers
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
cGMP mediated smooth muscle vasodilators
Adrenergic antagonists: Beta blockers
Calcium channel blockers
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Ventricular arrhythmias: Pathology review
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Cardiac tumors
Dressler syndrome
Familial hypercholesterolemia
Abetalipoproteinemia
Hypertriglyceridemia
Hyperlipidemia
Pheochromocytoma
Antihistamines for allergies
Mycobacterium avium complex (NORD)
Nocardia
Pneumocystis jirovecii (Pneumocystis pneumonia)
Cryptococcus neoformans
Coccidioidomycosis and paracoccidioidomycosis
Histoplasmosis
Blastomycosis
Aspergillus fumigatus

Transcript

Watch video only

Content Reviewers

Pseudomonas aeruginosa, or P. aeruginosa, is a gram-negative bacterium that is abundant in the environment.

It tends to opportunistically infect high-risk individuals, and is well known for its multi-drug resistance, making it hard to treat.

P. aeruginosa is an encapsulated, gram-negative, rod bacterium, that’s an obligate aerobe, so it uses oxygen for metabolism through cellular respiration.

It does not ferment lactose and does not make spores; but it’s catalase, citrate, and oxidase positive.

It has a flagellum, kind of like a tail, at one end for motility; and has multiple hair-like appendages, called pili, all over that help with adhesion to other cells.

It also has a number of multidrug efflux pumps that efficiently pump medications out of the bacteria making it resistant to a variety of antibiotics.

In addition it’s able to make beta-lactamases that degrade beta-lactam antibiotics as well as aminoglycoside-modifying enzymes that alter aminoglycoside antibiotics - rendering them ineffective. In short, it’s defenses are strong.

P. aeruginosa is everywhere in the environment - in soil; in the home, and in hospitals - where it’s found on improperly cleaned medical equipment and devices, various surfaces, and on the hands of health care workers.

It can survive for months on dry surfaces and inanimate objects – but particularly loves humid or wet conditions; like hot tubs, contact lens cases, catheters, and medical ventilators.

Transmission can occur when broken skin or mucous membranes come in contact with contaminated surfaces; or when aerosols containing P. aeruginosa are inhaled after an infected person coughs or sneezes.

Now, a P. aeruginosa infection is actually not too common in the general population.

It’s an opportunistic bacterium, meaning that it frequently causes infections in high-risk individuals like those with cystic fibrosis, chronic granulomatous disease, and type 2 diabetes mellitus.

It’s also common among individuals with an immunodeficiency; IV drug abusers, or those with severe burns or deep wounds.

P. aeruginosa produces several virulence factors to help it invade epithelial cells and survive an attack from the immune system.

First, there’s endotoxin, a molecule that’s made up of a lipid and polysaccharide.

The endotoxin sits on the outer membrane of the bacteria, and it’s recognized by the immune system as being foreign and causes a really strong immune reaction that can cause extensive damage to the host cells.

Certain strains of P. aeruginosa also produce a mucoid exopolysaccharide capsule, and this contributes to the formation of a biofilm - a slimy, sticky, gummy material – that surrounds colonies of P. aeruginosa and acts like a shield to protect the bacteria from immune cells as well as antibiotics.

P. aeruginosa can also produce toxins that can be injected directly into the host epithelial cells through a type III secretion system.

It’s kind of like a fine needle that pierces the host cell and forms a tunnel between the P. aeruginosa and the host epithelial cell, allowing toxins to pass through.

P. aeruginosa also releases toxins into the extracellular environment.

For example, it releases phospholipase C which is an enzyme that degrades the host cell membrane causing the cell to lyse.

Other secreted toxins have to move within the cell to act.

For example, exotoxin A is released by P. aeruginosa into the extracellular environment and then taken up by nearby host cells where it targets ADP-ribosylation of elongation factor 2, which is a ribosomal protein.

Key Takeaways

Pseudomonas aeruginosa is an aerobic, gram-negative, rod-shaped bacterium commonly found in the environment, such as in soil, in the home, and in hospitals. It is known to opportunistically infect immunocompromised people, and for its multi-drug resistance that is hard to treat.

It is also known to form biofilms that provide it with extra protection against antibiotics on top of its preexisting multi-drug resistance. P. aeruginosa can cause a variety of infections, including urinary tract infections, wound infections, sepsis, and lung infections in people with cystic fibrosis. Treatment for P. aeruginosa infections is with antibiotics, such as aminoglycosides, carbapenems, and cephalosporins.